학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 618건 | 목록 1~20
Academic Journal
Dugas-Breit S; Heidelberg University, Medical Faculty Heidelberg, Department of Dermatology, and National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital Heidelberg, Heidelberg, Germany.; Forschner A; Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany.; Erdmann M; Department of Dermatology, Uniklinikum Erlangen, Comprehensive Cancer Center Erlangen - EMN, CCC WERA, Friedrich-Alexander-Universität Erlangen-Nürnberg, Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany.; Gutzmer R; Department of Dermatology, Johannes Wesling Medical Center Minden, Ruhr University Bochum, Minden, Germany.; Kähler KC; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Germany.; Holst I; Department of Dermatology, Elbe Kliniken Stade-Buxtehude, Buxtehude, Germany.; Brekner A; Department of Dermatology, University Hospital Mainz, Mainz, Germany.; Franklin C; Department of Dermatology and Venereology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Sindrilaru A; Department of Dermatology, University Hospital Ulm, Ulm, Germany.; Zimmer L; Department of Dermatology, University Hospital Essen, Essen, Germany.; Heinzerling L; Department of Dermatology, Uniklinikum Erlangen, Comprehensive Cancer Center Erlangen - EMN, CCC WERA, Friedrich-Alexander-Universität Erlangen-Nürnberg, Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany; Department of Dermatology, Ludwig-Maximilians-University München, München, Germany.; Utikal J; Clinical Cooperation Unit Dermato-Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany; DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.; Meier F; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany, and Skin Cancer Center at the National Center for Tumor Diseases and University Cancer Centre Dresden, Dresden, Germany.; Bender A; Department of Dermatology and Allergology, University Hospital of Marburg, Marburg, Germany.; Berking C; Department of Dermatology, Uniklinikum Erlangen, Comprehensive Cancer Center Erlangen - EMN, CCC WERA, Friedrich-Alexander-Universität Erlangen-Nürnberg, Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany.; Garbe C; Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany.; Weichenthal M; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Germany.; Schadendorf D; Department of Dermatology, University Hospital Essen, Essen, Germany.; Hauschild A; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Germany.; Gschnell M; Department of Dermatology and Allergology, University Hospital of Marburg, Marburg, Germany.; Mohr P; Department of Dermatology, Elbe Kliniken Stade-Buxtehude, Buxtehude, Germany.; Hassel JC; Heidelberg University, Medical Faculty Heidelberg, Department of Dermatology, and National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital Heidelberg, Heidelberg, Germany. Electronic address: jessica.hassel@med.uni-heidelberg.de.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Kähler KC; University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.; Hassel JC; Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Ziemer M; Skin Cancer Center, University Hospital Leipzig, Leipzig, Germany.; Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Meier F; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; Skin Cancer Center, University Cancer Centre and National Center for Tumor Diseases, Dresden, Germany.; Flatz L; Department of Dermatology, University Hospital of Tuebingen, Tuebingen, Germany.; Gaudy-Marqueste C; Dermatology and Skin Cancer Department, APHM, CRCM INSERM U1068, CNRS U7258, La Timone Hospital, Aix-Marseille University, Marseille, France.; Zimmer L; Westdeutsches Tumorzentrum (WTZ), University Hospital Essen, Essen, Germany; National Center for Tumor Diseases (NCT-West), Campus Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, Essen, Germany; Research Alliance Ruhr, Research Center One Health, Essen, Germany; University Duisburg-Essen, Campus Essen, Essen, Germany.; Santinami M; Istituto Nazionale dei Tumori (INT), Fondazione IRCCS, Milano, Italy.; Russano F; Istituto Oncologico Veneto (IOV), IRCCS, Padua, Italy.; von Wasielewski I; Department of Dermatology, Allergology and Venerology, Claudia von Schilling Comprehensive Cancer Center, Hannover Medical School, Hannover.; Eigentler TK; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Maio M; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.; Zalaudek I; Department of Dermatology and Venereology of the Medical University of Triest, Triest, Italy.; Haferkamp S; University of Regensburg, Regensburg, Germany.; Quaglino P; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.; Welzel J; Department of Dermatology, University Hospital Augsburg, Augsburg, Germany; Bavarian Cancer Research Center BZKF, Augsburg, Germany.; Röcken C; University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.; Enk A; Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Simon JC; Skin Cancer Center, University Hospital Leipzig, Leipzig, Germany.; Świtaj T; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Garzarolli M; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; Skin Cancer Center, University Cancer Centre and National Center for Tumor Diseases, Dresden, Germany.; Amaral T; Department of Dermatology, University Hospital of Tuebingen, Tuebingen, Germany.; Malissen N; Dermatology and Skin Cancer Department, APHM, CRCM INSERM U1068, CNRS U7258, La Timone Hospital, Aix-Marseille University, Marseille, France.; Livingstone E; Westdeutsches Tumorzentrum (WTZ), University Hospital Essen, Essen, Germany; National Center for Tumor Diseases (NCT-West), Campus Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, Essen, Germany; Research Alliance Ruhr, Research Center One Health, Essen, Germany; University Duisburg-Essen, Campus Essen, Essen, Germany.; Elia G; Philochem AG, Otelfingen, Switzerland.; Covelli A; Philogen S.p.A., Siena, Italy.; Lorizzo K; Philogen S.p.A., Siena, Italy.; Neri D; Philogen S.p.A., Siena, Italy.; Mulatto S; Philogen S.p.A., Siena, Italy.; Parca A; Philogen S.p.A., Siena, Italy.; Pizzichi B; Philogen S.p.A., Siena, Italy.; Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.; Garbe C; Department of Dermatology, University Hospital of Tuebingen, Tuebingen, Germany.; Robert C; Gustave Roussy and Paris-Saclay University, Villejuif-Paris, France.; Schadendorf D; Westdeutsches Tumorzentrum (WTZ), University Hospital Essen, Essen, Germany; National Center for Tumor Diseases (NCT-West), Campus Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, Essen, Germany; Research Alliance Ruhr, Research Center One Health, Essen, Germany; University Duisburg-Essen, Campus Essen, Essen, Germany.; Hauschild A; University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany. Electronic address: ahauschild@dermatology.uni-kiel.de.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Livingstone E; Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, Essen, Germany; National Center for Tumor Diseases (NCT-West), Campus Essen, Essen, Germany.; Gogas HJ; First Department of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Kandolf L; Dermatology Department, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia.; Meier F; Department of Dermatology, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany; Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases, Dresden, Germany.; Eigentler TK; Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Centre for Dermatooncology, Department of Dermatology, Eberhard-Karls University Tübingen, Tübingen, Germany.; Ziemer M; Department of Dermatology, Universitätsklinikum Leipzig, Leipzig, Germany.; Terheyden P; Department of Dermatology, University Hospital Schleswig-Holstein, Lübeck, Germany.; Gesierich A; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany.; Herbst RA; Department of Dermatology, HELIOS-Klinikum Erfurt, Erfurt, Germany.; Kähler KC; Department of Dermatology, Venerology, and Allergology, University Hospital Schleswig-Holstein, Kiel, Germany.; Ziogas DC; Internal Medicine Department, Laiko General Hospital of Athens, Athens, Greece.; Mijušković Ž; Dermatology Department, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia.; Garzarolli M; Department of Dermatology, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany; Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases, Dresden, Germany.; Garbe C; Centre for Dermatooncology, Department of Dermatology, Eberhard-Karls University Tübingen, Tübingen, Germany.; Roesch A; Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, Essen, Germany; National Center for Tumor Diseases (NCT-West), Campus Essen, Essen, Germany.; Ugurel S; Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, Essen, Germany; National Center for Tumor Diseases (NCT-West), Campus Essen, Essen, Germany.; Gutzmer R; Department of Dermatology, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany; Department of Dermatology, Johannes Wesling Medical Center, Ruhr University Bochum, Minden, Germany.; Gaudy-Marqueste C; Aix-Marseille University, (APHM), Timone Hospital, Dermatology and Skin Cancer Department, Marseille, France.; Kiecker F; Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Dermatologie am Schlachtensee, Berlin, Germany.; Utikal J; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany; DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.; Hartmann M; European Consulting & Contracting in Oncology, Trier, Germany.; Miethe S; Alcedis GmbH, Giessen, Germany.; Eckhardt S; Alcedis GmbH, Giessen, Germany.; Zimmer L; Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, Essen, Germany; National Center for Tumor Diseases (NCT-West), Campus Essen, Essen, Germany.; Schadendorf D; Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, Essen, Germany; National Center for Tumor Diseases (NCT-West), Campus Essen, Essen, Germany; Research Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany. Electronic address: Dirk.Schadendorf@uk-essen.de.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Robert C; Gustave Roussy and Paris-Saclay University, Villejuif-Paris Sud, France. Electronic address: caroline.robert@gustaveroussy.fr.; Long GV; Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Larkin J; Royal Marsden NHS Foundation Trust, London, United Kingdom.; Wolchok JD; Meyer Cancer Center, Weill Cornell Medical College, New York, NY, USA.; Hassel JC; Heidelberg University, Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital Heidelberg, Heidelberg, Germany.; Schadendorf D; University Hospital Essen, West German Cancer Center and German Cancer Consortium, Partner Site Essen, Essen, Germany & National Center for Tumor Diseases (NCT)-West, Campus Essen, & Research Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany.; Hodi FS; Dana-Farber Cancer Institute, Boston, MA, USA.; Lebbé C; Université Paris Cité, AP-HP Dermatolo-oncology, Cancer Institute APHP.nord Paris-cité, INSERM U976, Saint-Louis Hospital, Paris, France.; Grob JJ; Aix-Marseille University, APHM Timone, Marseille, France.; Hyngstrom JR; Huntsman Cancer Institute, Salt Lake City, UT, USA.; Wagstaff J; Singleton Hospital, South West Wales Cancer Institute & Swansea University College of Medicine, Swansea, United Kingdom.; Chesney J; University of Louisville, Louisville, KY, USA.; Butler MO; Princess Margaret Cancer Centre, Department of Medical Oncology, Department of Immunology, University of Toronto, Toronto, ON, Canada.; Bechter O; Leuven Cancer Institute, University Hospitals Leuven, Belgium.; Márquez-Rodas I; General University Hospital Gregorio Marañón, Madrid, Spain.; Pavlick AC; Meyer Cancer Center, Weill Cornell Medical College, New York, NY, USA.; Durani P; Bristol Myers Squibb, Princeton, NJ, USA.; Pe Benito M; Bristol Myers Squibb, Princeton, NJ, USA.; Wang P; Bristol Myers Squibb, Princeton, NJ, USA.; Postow MA; Meyer Cancer Center, Weill Cornell Medical College, New York, NY, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Amaral T; Skin Cancer Clinical Trials Center-University of Tuebingen, Tuebingen, Germany.; Ottaviano M; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Napoli, Italy.; Arance A; Department of Medical Oncology and IDIBAPS, Hospital Clinic y Provincial de Barcelona, Barcelona, Spain.; Blank C; Department of Medical Oncology and Division of Immunology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Ziekenhuis (NKI), Amsterdam; Leiden University Medical Center (LUMC), Leiden, The Netherlands; University Clinic Regensburg, Regensburg, Germany.; Chiarion-Sileni V; Department of Oncology, Melanoma Unit, Istituto Oncologico Veneto, IOV-IRCCS, Padova, Italy.; Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark.; Dummer R; Department of Dermatology, Skin Cancer Center, USZ-University Hospital Zürich, University of Zürich, Zürich, Switzerland.; Garbe C; Department of Dermatology, Center for DermatoOncology, University Hospital Tuebingen, Tuebingen, Germany.; Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center and The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, USA.; Gogas H; First Department of Medicine, School of Medicine, National and Kapodistrian University of Athens-School of Medicine, Athens, Greece.; Guckenberger M; Department of Radiation Oncology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.; Haanen J; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, Leiden University Medical Center (LUMC), Leiden, The Netherlands; Oncology Service, Melanoma Clinic, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Hamid O; Medical Oncology, Cutaneous Malignancies, The Angeles Clinic and Research Institute, A Cedars Sinai Affiliate, Los Angeles, USA.; Hauschild A; Department of Dermatology, UKSH-Universitätsklinikum Schleswig-Holstein-Campus Kiel, Kiel, Germany.; Höller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Lebbé C; Université Paris Cite, AP-HP Dermato-oncology and CIC, Cancer Institute APHP, Nord Paris Cité, INSERM U976, Saint Louis Hospital, Paris, France.; Lee RJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.; Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Department Medical Oncology, Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia.; Lorigan P; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.; Muñoz Couselo E; Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Nathan P; Mount Vernon Cancer Centre, Northwood, UK.; Robert C; Department of Oncology, Institut Gustave Roussy and Paris-Saclay University, Villejuif, France.; Romano E; Department of Oncology, Center for Cancer Immunotherapy, Institut Curie, Paris, France.; Schadendorf D; Department of Dermatology, WTZ-Westdeutsches Tumorzentrum Essen, National Center for Tumor Diseases (NCT-West), Campus Essen, Essen, Germany; University Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany.; Sondak V; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, USA.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; van Akkooi ACJ; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia.; Michielin O; Department of Oncology, Geneva University Hospital, Geneva, Switzerland.; Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE; In Process
검색 결과 제한하기
제한된 항목
[AR] Schadendorf, D
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어